Nuvectis Pharma Inc.
5.48
-0.16 (-2.84%)
At close: Jan 15, 2025, 2:59 PM

Nuvectis Pharma Statistics

Share Statistics

Nuvectis Pharma has 19.32M shares outstanding. The number of shares has increased by 8.74% in one year.

Shares Outstanding 19.32M
Shares Change (YoY) n/a
Shares Change (QoQ) 3.58%
Owned by Institutions (%) n/a
Shares Floating 8.28M
Failed to Deliver (FTD) Shares 1.74K
FTD / Avg. Volume 0.94%

Short Selling Information

The latest short interest is 1.44M, so 7.48% of the outstanding shares have been sold short.

Short Interest 1.44M
Short % of Shares Out 7.48%
Short % of Float 16.27%
Short Ratio (days to cover) 6.98

Valuation Ratios

The PE ratio is -5.83 and the forward PE ratio is -11.44.

PE Ratio -5.83
Forward PE -11.44
PS Ratio 0
Forward PS 36.9
PB Ratio 10.63
P/FCF Ratio -8.13
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nuvectis Pharma Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 0.

Current Ratio 2.75
Quick Ratio 2.75
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -1.82% and return on capital (ROIC) is -187.66%.

Return on Equity (ROE) -1.82%
Return on Assets (ROA) -1.16%
Return on Capital (ROIC) -187.66%
Revenue Per Employee 0
Profits Per Employee -1.71M
Employee Count 13
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -23.65% in the last 52 weeks. The beta is 0.4, so Nuvectis Pharma 's price volatility has been higher than the market average.

Beta 0.4
52-Week Price Change -23.65%
50-Day Moving Average 5.86
200-Day Moving Average 6.53
Relative Strength Index (RSI) 51.7
Average Volume (20 Days) 185.16K

Income Statement

Revenue n/a
Gross Profit -22.90M
Operating Income -22.90M
Net Income -22.26M
EBITDA -22.90M
EBIT n/a
Earnings Per Share (EPS) -1.43
Full Income Statement

Balance Sheet

The company has 19.13M in cash and 0 in debt, giving a net cash position of 19.13M.

Cash & Cash Equivalents 19.13M
Total Debt 0
Net Cash 19.13M
Retained Earnings -54.24M
Total Assets 17.31M
Working Capital 10.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.95M and capital expenditures 0, giving a free cash flow of -15.95M.

Operating Cash Flow -15.95M
Capital Expenditures 0
Free Cash Flow -15.95M
FCF Per Share -1.03
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NVCT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -25.31%
FCF Yield -14.62%
Dividend Details

Analyst Forecast

The average price target for NVCT is $21, which is 271.7% higher than the current price. The consensus rating is "Buy".

Price Target $21
Price Target Difference 271.7%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 1.67
Piotroski F-Score 1